Abstract
The first breast implants were created by Cronin [1] in 1962, and after that there was a big evolution in them. The initial concern was to find a biocompatible sort of material: properly tolerated by the body and also inert. In 1958, Scales [2] proposed a review of the criteria needed for implant considering biocompatibility:
-
No chemical activity
-
No physical transformations when in contact with the body
-
No stimulus to inflammatory reactions or foreign material
-
Not being carcinogenic
-
Able to stand mechanical forces
-
Easy to produce at considerable low cost
-
Able to be sterilized
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cronin TD, Gerow FJ (1963) Augmentation mammaplasty: a new “natural feel” prosthesis. Excerpta Medica Foundation, Amsterdam, p 41
Scales JT (2004) Biological and mechanical factors in prosthetic surgery. In: Gilles L (ed) Modern trends in surgical material. Butterworth, London
Barnard JJ, Todd EL, Wilson WG, Mielcarek R, Rohrich RJ (1997) Distribution of organosilicon polymers in augmentation mammaplasties at autopsy. Plast Reconstr Surg 100:197–203
Gaubitz M, Jackisch C, Domschke W, Heindel W, Pfleiderer B (2002) Silicone breast implants: correlation between implants ruptures, magnetic resonance spectroscopically estimated silicone presence in the liver, antibody status and clinical symptoms. Rheumatology (Oxford) 41:129–135
Kessler DA (1992) The basis of FDA’s decision on breast implants. N Engl J Med 326:1713–1715
Chan SC, Birdsell DC, Gradeen CY (1991) Urinary excretion of free toluenediamines in a patient with polyurethane-covered breast implants. Clin Chem 37:2143–2145
Fagrell D, Berggren A, Tarpila E (2001) Capsular contracture around saline-filled fine textured and smooth mammary implants: a prospective 7.5-year follow-up. Plast Reconstr Surg 108:2108–2112
Soubirac L, Jougla E, Hezard L, Grolleu JL, Chavoin JP (2002) Deflation of breast implants, pre-filled with saline or hydrogel. Results and analysis of 650 treated patients. Ann Chir Plast Esthet 47:273–279
Little JW, Golembe EV, Fisher JB (1981) The “living bra” in immediate and delayed reconstruction of the breast following mastectomy for malignant and nonmalignant disease. Plast Reconstr Surg 68:392
Heneghan C (2012) The saga of Poly Implant Prosthèse breast implants. BMJ 344:e306
Smahel J (1978) Tissue reactions to breast implant coated with polyurethane. Plast Reconstr Surg 61:80–85
Benoit FM (1993) Degradrations of polyurethane foams used in Meme breast implants. J Biomed Mater Res 27:1341
Cordeiro PG, Pusic AL, Disa JJ, McCormick B, VanZee K (2004) Which is the best position for the remote injection dome using the adjustable expander/prosthesis in breast reconstruction. Plast Reconstr Surg 113:877–881
Sergotti TJ, Limoli JP, Baldwin CM Jr, Laub DR (1986) Human adjuvant disease, possible autoimmune disease after silicone implantation: a review of the literature, case studies and speculation for the future. Plast Reconstr Surg 78:104–114
Ferguson JH (1997) Silicone breast implants and neurologic disorders. Neurology 48:1504–1507
Hochberg MC (1996) Lack of association between augmentation mammaplasty and systemic sclerosis (scleroderma). Arthritis Rheum 39:1125–1131
Friis S, Mellemkjaer L, McLaughlin JK et al (1997) Connective tissue disease and other rheumatic conditions following breast implants in Denmark. Ann Plast Surg 39:1–8
Sanchez-Guerrero J (1995) Silicone breast implants and the risk of connective tissue disease and symptoms. N Engl J Med 332:1667–1670
Sherine G, O’Fallon WM, Kurland LT et al (1994) Risk of connective tissue diseases and other disorders after breast implantation. N Engl J Med 330:1697–1702
Miller AS, Willard V, Kline K et al (1998) Absence of longitudinal changes in rheumatological parameters after silicone breast implantation: a prospective 13 year study. Plast Reconstr Surg 102:2299–2303
Nyren O, Yin L, Josefsson S et al (1998) Risk of connective tissue disease and related disorders among women with breast implants: a nation-wide retrospective cohort study in Sweden. Br Med J 316:417–422
Petit JY, Le MG, Mouriesse H, Rietjens M, Gill P, Contesso G, Lehmann A (1994) Can breast reconstruction with gel-filled silicone implants increase the risk of death and second primary cancer in patients treated by mastectomy for breast cancer? Plast Reconstr Surg 94:115–119
Petit JY, Le MG, Rietjens M, Contesso G, Lehmann A, Mouriesse H (1998) Does long-term exposure to gel-filled silicone implants increase the risk of relapse after breast cancer? Tumori 84:525–528
Berkel H, Birdsell DC, Jenkins H (1992) Breast augmentation: a risk factor for breast cancer? N Engl J Med 326:1649
Deapen DM, Pike MC, Casagrande JT et al (1986) The relationship between breast cancer and augmentation mammaplasty: an epidemiologic study. Plast Reconstr Surg 77:548
Deapen DM, Brody GS (1992) Augmentation mammaplasty and breast cancer: a 5-years update of the Los Angeles Study. Plast Reconstr Surg 89:660
Marotta JS, Goldberg EP, Habal MB, Amery DP, Martin PJ, Urbaniak DJ, Widenhouse CW (2002) Silicone gel breast implant failure: evaluation of properties of shells and gels for explanted prostheses and meta-analysis of literature rupture data. Ann Plast Surg 49:227–247
Ikeda DM, Borofsky HB, Herfkens RJ, Sawyer-glover AM, Birdwell RL, Glover GH (1999) Silicone breast implant rupture: pitfalls of magnetic resonance imaging and relative efficacies of magnetic resonance, mammography and ultrasounds. Plast Reconstr Surg 104:2054
Pfleiderer B, Campbell T, Hulka CA et al (1996) Silicone gel-filled breast implants in women: findings at H-1 MR spectroscopy. Radiology 201:777–783
Gaubitz M, Jackisch C, Domschke W, Heindel W, Pfleiderer B (2002) Silicone breast implants: correlation between implant ruptures, magnetic resonance spectroscopically estimated silicone presence in the liver, antibody status and clinical symptoms. Rheumatology 41:129–135
Spear SL, Baker JL Jr (1995) Classification of capsular contracture after prosthetic breast reconstruction. Plast Reconstr Surg 96:1119–1123
Loch-Wilkinson A, Beath KJ, Knight RJW et al (2017) Breast implant-associated anaplastic large cell lymphoma in Australia and New Zealand: high-surface-area textured implants are associated with increased risk. Plast Reconstr Surg 140(4):645–654
De Boer M, van Leeuwen FE, Hauptmann M et al (2018) Breast implants and the risk of anaplastic large-cell lymphoma in the breast. JAMA Oncol 4(3):335–341
Clemens MW, Medeiros LJ, Butler CE et al (2016) Complete surgical excision is essential for the management of patients with breast implant-associated anaplastic large-cell lymphoma. J Clin Oncol 34(2):160–168
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Rietjens, M., da Costa Vieira, M.A., Urban, C., Lohsiriwat, V. (2019). History and Development of Breast Implants. In: Urban, C., Rietjens, M., El-Tamer, M., Sacchini, V.S. (eds) Oncoplastic and Reconstructive Breast Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-62927-8_35
Download citation
DOI: https://doi.org/10.1007/978-3-319-62927-8_35
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-62925-4
Online ISBN: 978-3-319-62927-8
eBook Packages: MedicineMedicine (R0)